Greg Habstritt News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Canada's Largest Psychedelic Industry Conference to Coincide with Mental Health Awareness Week, Offering Hope to the Current Mental Health Crisis News provided by Share this article Share this article Among the featured agenda of international speakers will be Michael Pollan, Journalist and Author of the #1 New York Times Best-Seller, "How To Change Your Mind" CALGARY, AB, March 3, 2021 /CNW/ - CATALYST Presents Foundation (" CATALYST"), an Alberta-based not-for-profit event company focused on advancing the psychedelic medicine movement in Canada, announced the second annual  CATALYST Summ...

Share this article The completed equity investment strengthens ties between MINDCURE and ATMA VANCOUVER, BC, March 2, 2021 /PRNewswire/ - Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) ( "MINDCURE" or the "Company"), a leader in developing technology to advance psychedelic-related treatments, is pleased to announce the completion of its initial strategic equity investment of equal to approximately 13% ownership in ATMA Journey Centers Inc. (" ATMA") in accordance with the terms of the letter of intent (the " LOI") announced on January 12, 2021. MINDCURE's initial strategic inv...

/CNW/ - ATMA Journey Centers Inc. ("ATMA"), an Alberta-based company focused on delivering innovative psychedelic-assisted therapies internationally, announced...

Share this article Share this article ATMA Journey Centers and SYNTAC Institute collaborate to submit a Group Application for Section 56 Exemption from Health Canada to access psychedelic-assisted therapy CALGARY, AB, Feb. 2, 2021 /CNW/ -  ATMA Journey Centers Inc. (" ATMA"), an Alberta-based company focused on delivering innovative psychedelic-assisted therapies internationally, announced today that it has submitted a Group Application for Section 56 Exemption to Health Canada on behalf of Canadians struggling with adverse mental and emotional health conditions. David Harder, Co-CEO of ATM...

Mind Cure Signs LOI to Acquire an Ownership Interest in Psychedelic Treatment Center ATMA, Selected by Section 56 Exempt Patient for Psilocybin Therapy News provided by Share this article Share this article The strategic partnership between Mind Cure and ATMA will bridge access to research locations for psychedelic drug research while providing patient data for iSTRYM , Mind Cure's digital therapeutics platform. VANCOUVER, BC, Jan. 12, 2021 /PRNewswire/ - Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) ( "Mind Cure" or the LOI") for strategic investment and commercial cooperatio...